The case was a tricky one, a surgery was inevitable. The patient had lost a lot of blood. He was also in severe pain. Then, ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

A team of researchers at Western Michigan University's Homer Stryker M.D. School of Medicine has made a monumental ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Teams of researchers are investigating empagliflozin and dapagliflozin in patients with autosomal dominant polycystic kidney disease (AD PKD).

Using a handheld dynamometer to assess hip flexion and abduction strength during dialysis was reliable and safe, researchers found in a cross-sectional study.“Subjects in stages 3 and 4 of [chronic ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

"This really means something to the patients," Gough told CNN. "The impact on not just kidney disease but also cardiovascular disease and on all-cause death."Ozempic and other semaglutide ...